Insights On Regulatory Compliance
-
Challenges In Developing Medical Devices From Animal-Based Biomaterials In China
11/11/2024
Bovine collagen, valued for biocompatibility and versatility, is gaining attention for medical devices in China as regulatory barriers ease, though safety assurances remain crucial.
- ICH E6(R3) In Effect: Transforming Quality Management For Cell And Gene Therapy Trials 1/29/2026
-
The CMC Regulatory Landscape During Product Development, Manufacturing
7/11/2025
Through case studies and practical insights spanning complex drug substance and drug products like ADCs, learn more about navigating complexities with integrated regulatory services and strategic guidance.
-
Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS
7/29/2025
Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.
-
A Strategically Positioned, Globally Credible CDMO Partner
4/7/2026
Strategic location, strong regulatory oversight, institutional stability, and deep expertise reduce risk, speed approvals, and enable reliable, long-term pharmaceutical development partnerships.
-
How To Achieve Right-First-Time Manufacturing
1/21/2026
Modernizing QC requires more than isolated fixes. Discover how cloud-based platforms unify systems, automate workflows, and improve data access to help labs reduce cycle times and minimize rework.
-
Maximizing Results For Viral Clearance Studies
7/25/2025
Explore virus strain selection and titer strategies to optimize viral clearance studies, covering regulatory expectations, study design, and execution best practices.
-
5 Trends Impacting CMOs In 2025
2/4/2025
In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.
-
Multispecific Antibodies: Key Challenges And Solutions To Enable A New Frontier In Cancer Treatment
11/14/2025
Multispecific antibodies are a newer class of cancer therapeutics addressing tumor complexity. Learn about the design, manufacturing, and regulatory challenges and integrated solutions accelerating their development.
-
Proven Strategies For GxP Compliance And Inspection Readiness
6/23/2025
Struggling with data integrity challenges? Discover proven strategies for GxP compliance and inspection readiness in this essential webinar. Learn to build a robust framework and avoid common pitfalls.